insights_auto
Why is ORX down 3.08%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEK 0.85
arrow_downward
-3.08%(-0.027) 1D
ኖቬም 16, 5:29:42 ከሰዓት ጂ ኤም ቲ+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEK 0.89
High
SEK 0.89
Low
SEK 0.82
Mkt. cap
297.56 ሚ
Avg. vol.
777.72 ሺ
Volume
415.89 ሺ
P/E ratio
0.06
52-wk high
SEK 22.55
52-wk low
SEK 0.80
EPS
SEK 13.61
Shares outstanding
35.13 ሚ
No. of employees
55
Open
SEK 0.89
High
SEK 0.89
Low
SEK 0.82
Mkt. cap
297.56 ሚ
Avg. vol.
777.72 ሺ
Volume
415.89 ሺ
P/E ratio
0.06
52-wk high
SEK 22.55
52-wk low
SEK 0.80
EPS
SEK 13.61
Shares outstanding
35.13 ሚ
No. of employees
55
News stories
From web sources and news partners
ChartMill
·
ከ45 ደቂቃዎች በፊት
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
marketscreener.com
·
ከ51 ደቂቃዎች በፊት
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
Stocktwits
·
ከ51 ደቂቃዎች በፊት
Morgan Stanley’s Mike Wilson Is Bullish On S&P 500 With A 15% Upside View For 2027
Traders Union
·
ከ2 ሰዓቶች በፊት
Peter Tuchman: S&P 500 loses over $800 billion in market cap
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com